OTAN

Información principal

  • Denominación comercial:
  • OTAN
  • formulario farmacéutico:
  • Gotas óticas
  • Usar para:
  • Humanos
  • Tipo de medicina:
  • medicamento alopático

Documentos

  • para el público en general:
  • El prospecto de información de este producto no está disponible actualmente, puede enviar una petición a nuestro servicio al cliente y le notificaremos tan pronto como nos sea posible para conseguirlo.


    Solicitar el prospecto de información al público.

Localización

  • Disponible en:
  • OTAN
    Cuba
  • Idioma:
  • español

Otros datos

Estado

  • Fuente:
  • CECMED - Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos - Cuba
  • Número de autorización:
  • 044-15d3
  • última actualización:
  • 10-05-2018

Ficha Técnica

RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO

Nombre del producto:

OTAN

Forma farmacéutica:

Gotas óticas

Fortaleza:

Presentación:

Frasco de PP con 15 mL.

Titular del Registro Sanitario, país:

Establecimientos Ancalmo S.A. de C.V., El Salvador.

Fabricante, país:

Laboratorios Ancalmo, El Salvador.

Número de Registro Sanitario:

044-15D3

Fecha de Inscripción:

11 de agosto de 2015

Composición:

Cada mL contiene:

Nitrofurazona

Sulfacetamida sódica

Urea

Tetracaína

Propilenglicol

Etanol csp

22,5 mg

50,0 mg

50,0 mg

20,0 mg

550,0 mg

Plazo de validez:

36 meses

Condiciones de almacenamiento:

Almacenar por debajo de 30ºC. Protéjase de la luz.

Indicaciones terapéuticas:

Otalgias y Otitis externa. La acción analgésica es inmediata debido al poder anestésico de la

tetracaína.

Contraindicaciones:

Hipersensibilidad a alguno de los componentes de la fórmula.

Precauciones:

Ver Advertencias.

Advertencias especiales y precauciones de uso:

Durante el embarazo y lactancia consultar a su médico.

Contiene Propilenglicol, puede causar irritación a la piel

Efectos indeseables:

personas

sensibles

puede

presentarse

dermatitis,

ocasiones

prurito

ardor

desaparecen al suspender el tratamiento.

Posología y método de administración:

Aplicar 2 o 3 gotas en el oído afectado o como el médico lo indique.

Interacción con otros productos medicinales y otras formas de interacción:

Puede inhibirse el metabolismo de un anestésico local, cuando se administra a pacientes

sometidos a tratamiento con inhibidores de la colinesterasa.

No utilice otros productos para los oídos sin consultar a su médico o profesional de la salud.

Uso en Embarazo y lactancia:

Ver Advertencias.

Efectos sobre la conducción de vehículos/maquinarias:

No procede.

Sobredosis:

Consúltele a su médico si ha tenido alguna reacción inusual o alérgica a este medicamento, ya

que generalmente no se ha presentado casos de alergias durante su uso.

En casos de sobredosis: ponerse en contacto inmediatamente con un centro de toxicológico o

una sala de urgencia si usted ha ingerido medicamento.

Solo para uso tópico externo.

Propiedades farmacodinámicas:

No se reporta.

Propiedades farmacocinéticas (Absorción, distribución, biotransformación, eliminación):

No se reporta.

Instrucciones

de

uso,

manipulación

y

destrucción

del

remanente

no

utilizable

del

producto:

No procede.

Fecha de aprobación/ revisión del texto: 11 de agosto de 2015.

  • El prospecto de información de este producto no está disponible actualmente, puede enviar una petición a nuestro servicio al cliente y le notificaremos tan pronto como nos sea posible para conseguirlo.

    Solicitar el prospecto de información al público.



  • Los documentos en otros idiomas están disponibles aquí

20-10-2018

Scientific Opinion of Flavouring Group Evaluation 411 (FGE.411): 2‐(4‐methylphenoxy)‐N‐(1H‐pyrazol‐3‐yl)‐N‐(thiophen‐2‐ylmethyl)acetamide from chemical group 30 (miscellaneous substances)

Scientific Opinion of Flavouring Group Evaluation 411 (FGE.411): 2‐(4‐methylphenoxy)‐N‐(1H‐pyrazol‐3‐yl)‐N‐(thiophen‐2‐ylmethyl)acetamide from chemical group 30 (miscellaneous substances)

Published on: Fri, 19 Oct 2018 00:00:00 +0200 EFSA was requested to deliver a scientific opinion on the implications for human health of the flavouring substance 2‐(4‐methylphenoxy)‐N‐(1H‐pyrazol‐3‐yl)‐N‐(thiophen‐2‐ylmethyl)acetamide [FL‐no: 16.133], in the Flavouring Group Evaluation 411 (FGE.411), according to Regulation (EC) No 1331/2008 of the European Parliament and of the Council. The substance has not been reported to occur in natural source materials of botanical or animal origin. It is intende...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Update of the Xylella spp. host plant database

Update of the Xylella spp. host plant database

Published on: Mon, 10 Sep 2018 00:00:00 +0200 Following a request from the European Commission, EFSA periodically updates the database on the host plants of Xylella spp. While previous editions of the database (2015 and 2016) dealt with the species Xylella fastidiosa only, this database version addresses the whole genus Xylella, including therefore both species X. fastidiosa and Xylella taiwanensis. The database now includes information on host plants of Xylella spp. retrieved from scientific literature...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Risk assessment of substances used in food supplements: the example of the botanical Gymnema sylvestre

Risk assessment of substances used in food supplements: the example of the botanical Gymnema sylvestre

Published on: Tue, 28 Aug 2018 00:00:00 +0200 Botanicals and preparations derived from these are among the substances frequently added to foods and food supplements, yet the safety of many botanicals has not been systematically assessed. In the context of the EU‐FORA fellowship programme, the fellow performed an assessment on the safety of the botanical Gymnema sylvestre, in accordance with EFSA's guidance on the assessment of safety of botanicals. Although preparations of G. sylvestre are marketed as f...

Europe - EFSA - European Food Safety Authority Publications

12-7-2018

Plant health and citizen science: ANSES takes part in an operation to detect giant ragweed

Plant health and citizen science: ANSES takes part in an operation to detect giant ragweed

ANSES is taking part in a citizen observation mission targeting the giant ragweed plant (Ambrosia trifida) in partnership with the Tela Botanica Association and the Ragweed Observatory. Ambrosia trifidais an invasive alien species posing a threat to health and agriculture, because it releases pollen that is highly allergenic to humans and colonises crops leading to yield losses.

France - Agence Nationale du Médicament Vétérinaire

22-6-2018

Kratom (mitragyna speciosa) Powder Products by Gaia Ethnobotanical: Recall - Due to Potential Salmonella Contamination

Kratom (mitragyna speciosa) Powder Products by Gaia Ethnobotanical: Recall - Due to Potential Salmonella Contamination

The products have been found by the FDA via sample testing and finding to have salmonella contamination. In lieu of such FDA findings the company has implemented standard operating procedures and sterilization processes in accordance to FDA guidelines

FDA - U.S. Food and Drug Administration

21-6-2018

Gaia Ethnobotanical, LLC., Voluntarily Recalls Kratom Products Due to Potential Salmonella Contamination

Gaia Ethnobotanical, LLC., Voluntarily Recalls Kratom Products Due to Potential Salmonella Contamination

Gaia Ethnobotanical, LLC., is voluntarily recalling all kratom (mitragyna speciosa) powder products, with Lot No.: 0102031800 it manufactured, processed, packed, and/or held, between March 18, 2018 to March 30, 2018 to the consumer level. The products have been found by the U.S. Food and Drug Administration (“FDA”) via sample testing and finding to have salmonella contamination. In lieu of such FDA findings the company has implemented standard operating procedures and sterilization processes in accordanc...

FDA - U.S. Food and Drug Administration

2-6-2018

Solve Botanical Slimming capsules

Solve Botanical Slimming capsules

Safety advisory - Solve Botanical Slimming capsules pose a serious risk to your health and should not be taken

Therapeutic Goods Administration - Australia

4-5-2018

Badger Botanicals Recalls Red Suma, Green Suma, Green Hulu 2, And Red Hulu 2 Kratom Supplements Because Of Possible Salmonella Health Risk

Badger Botanicals Recalls Red Suma, Green Suma, Green Hulu 2, And Red Hulu 2 Kratom Supplements Because Of Possible Salmonella Health Risk

Badger Botanicals, LLC of Springville, Utah is recalling Green Suma, Red Suma, Green Hulu 2, and Red Hulu 2 kratom dietary supplements sold directly to consumers via the company website from January 1st, 2018 to April l 12th, 2018 in pouches of 250g, because it has the potential to be contaminated with Salmonella.

FDA - U.S. Food and Drug Administration

19-4-2018

NxtGen Botanicals Maeng Da Kratom by NGB Corp.: Recall - Possible Salmonella Contamination

NxtGen Botanicals Maeng Da Kratom by NGB Corp.: Recall - Possible Salmonella Contamination

NGB Corp. of West Jordan, Utah is voluntarily recalling NxtGen Botanicals Maeng Da Kratom labeled bottles of encapsulated product because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infec...

FDA - U.S. Food and Drug Administration

20-6-2011

Warning against the tanning product Melanotan

Warning against the tanning product Melanotan

The Danish Medicines Agency repeats its warning against using the illegal product Melanotan because its effect is not documented and because of the absence of studies of its potential side effects. The Danish Medicines Agency urges everyone who uses Melanotan to stop using it and to contact their doctor if concerned.

Danish Medicines Agency

11-8-2008

Warning against the product Melanotan

Warning against the product Melanotan

The Danish Medicines Agency has been made aware of the product, Melanotan, which is sold via the internet. The product is marketed as a product that increases pigmentation, providing tanned skin and protection against the harmful rays of the sun, implying that it may prevent skin cancer. However, this effect has not been documented.

Danish Medicines Agency

No hay novedades relativo a este producto.